Neuphoria Therapeutics Inc. Form 10-K: Annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-09-18: Form 10-K; Period of report 2026-06-30; Description 10-K; Document neup-20260630.htm.
- 2025-09-29: Form 10-K; Period of report 2025-06-30; Description 10-K; Document neup-20250630.htm.
- 2024-09-30: Form 10-K; Period of report 2024-06-30; Description ANNUAL REPORT; Document ea0213573-10k_bionomic.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-09-18 | 10-K | 2026-06-30 | 10-K | neup-20260630.htm |
| 2025-09-29 | 10-K | 2025-06-30 | 10-K | neup-20250630.htm |
| 2024-09-30 | 10-K | 2024-06-30 | ANNUAL REPORT | ea0213573-10k_bionomic.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |